Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
81.64
Dollar change
+1.47
Percentage change
1.83
%
IndexS&P 500 P/E29.56 EPS (ttm)2.76 Insider Own0.07% Shs Outstand1.31B Perf Week-0.02%
Market Cap104.68B Forward P/E14.01 EPS next Y5.83 Insider Trans-5.34% Shs Float1.28B Perf Month-4.14%
Income3.68B PEG6.71 EPS next Q1.20 Inst Own88.81% Short Float1.04% Perf Quarter-2.12%
Sales32.36B P/S3.23 EPS this Y4.73% Inst Trans1.47% Short Ratio2.15 Perf Half Y-0.52%
Book/sh38.29 P/B2.13 EPS next Y7.00% ROA4.06% Short Interest13.32M Perf Year-7.56%
Cash/sh6.24 P/C13.08 EPS next 5Y4.40% ROE7.23% 52W Range68.84 - 91.00 Perf YTD-0.90%
Dividend Est.2.73 (3.34%) P/FCF20.13 EPS past 5Y-4.12% ROI4.90% 52W High-10.29% Beta0.83
Dividend TTM2.76 (3.38%) Quick Ratio1.55 Sales past 5Y1.24% Gross Margin60.35% 52W Low18.59% ATR (14)1.39
Dividend Ex-DateJun 28, 2024 Current Ratio2.03 EPS Y/Y TTM-2.06% Oper. Margin17.93% RSI (14)48.62 Volatility1.66% 1.66%
Employees95000 Debt/Eq0.52 Sales Y/Y TTM3.64% Profit Margin11.36% Recom2.40 Target Price93.01
Option/ShortYes / Yes LT Debt/Eq0.49 EPS Q/Q-44.22% Payout99.87% Rel Volume1.79 Prev Close80.17
Sales Surprise1.64% EPS Surprise0.63% Sales Q/Q0.53% EarningsMay 23 BMO Avg Volume6.21M Price81.64
SMA20-0.37% SMA50-0.22% SMA2000.66% Trades Volume11,094,382 Change1.83%
Date Action Analyst Rating Change Price Target Change
May-30-24Initiated Goldman Sell $83
Jul-19-23Initiated Robert W. Baird Neutral $90
Jun-30-23Initiated CL King Buy $106
May-30-23Upgrade Morgan Stanley Equal-Weight → Overweight $104
Apr-24-23Upgrade Wells Fargo Equal Weight → Overweight $77 → $100
Mar-29-23Downgrade UBS Buy → Sell $127 → $79
Jan-09-23Downgrade RBC Capital Mkts Outperform → Sector Perform $102 → $89
Nov-23-22Downgrade Oppenheimer Outperform → Perform $106 → $85
Nov-23-22Downgrade Citigroup Buy → Neutral $108 → $85
Nov-16-22Downgrade Deutsche Bank Buy → Hold $85
Jun-21-24 06:30PM
06:53AM
Jun-20-24 04:15PM
01:35PM
08:39AM
06:00AM Loading…
06:00AM
Jun-18-24 06:00AM
Jun-17-24 07:10AM
Jun-14-24 04:30PM
06:15AM
Jun-13-24 03:00PM
Jun-11-24 08:15AM
07:30AM
Jun-10-24 05:30PM
06:00AM
11:14AM Loading…
Jun-07-24 11:14AM
Jun-06-24 11:35PM
02:58PM
02:58PM
02:25PM
12:50PM
08:39AM
08:00AM
07:43AM
Jun-05-24 03:23PM
07:00AM
Jun-03-24 02:27PM
06:57AM
06:00AM
Jun-01-24 03:40AM
09:18PM Loading…
May-30-24 09:18PM
04:13PM
May-29-24 05:10PM
02:30PM
07:09AM
May-28-24 02:38PM
May-27-24 12:46PM
May-26-24 04:51AM
May-24-24 10:00AM
May-23-24 02:00PM
01:38PM
01:14PM
11:50AM
11:03AM
10:52AM
10:36AM
09:30AM
08:13AM
07:55AM
07:52AM
07:10AM
07:02AM
06:52AM
06:45AM
06:00AM
May-22-24 09:06AM
May-21-24 03:04PM
01:24AM
May-20-24 04:22PM
10:54AM
10:52AM
09:57AM
09:15AM
08:31AM
06:51AM
06:12AM
May-19-24 08:09AM
08:00AM
May-17-24 04:31PM
11:35AM
09:00AM
May-16-24 08:00AM
May-14-24 04:44PM
12:00PM
11:19AM
08:21AM
May-13-24 05:50PM
04:58PM
12:10PM
May-11-24 07:11AM
May-10-24 12:45PM
09:10AM
May-09-24 12:51PM
10:00AM
09:00AM
08:45AM
07:00AM
May-08-24 12:15PM
May-07-24 06:22AM
May-06-24 10:50PM
05:50PM
12:00PM
09:00AM
May-04-24 10:26AM
May-03-24 10:41AM
09:03AM
08:30AM
May-02-24 03:18PM
May-01-24 08:15AM
Apr-29-24 05:50PM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Martha GeoffreyChairman and CEOJun 07 '24Option Exercise62.7619,1131,199,532162,461Jun 11 06:53 PM
Martha GeoffreyChairman and CEOJun 07 '24Sale83.7719,1131,601,001143,348Jun 11 06:53 PM
Marinaro MichaelEVP & President, Surgical OUApr 08 '24Sale83.1485471,00227,925Apr 09 04:08 PM
Salmon SeanEVP & President CardiovascularFeb 21 '24Option Exercise69.0730,6952,120,12178,984Feb 23 05:18 PM
Salmon SeanEVP & President CardiovascularFeb 21 '24Sale85.1330,6952,613,05548,289Feb 23 05:18 PM
Wall Brett A.EVP & Pres NeuroscienceDec 19 '23Sale82.174,997410,60328,910Dec 20 11:41 AM
Smith Gregory LEVP Global Ops & Supply ChainAug 23 '23Sale83.8410,000838,40046,723Aug 25 03:21 PM
Wall Brett A.EVP & Pres NeuroscienceAug 14 '23Sale83.381,00083,38033,573Aug 16 05:16 PM
Marinaro MichaelEVP & President, Surgical OUAug 04 '23Sale84.111,352113,71728,930Aug 07 08:47 PM
Wall Brett A.EVP & Pres NeuroscienceJul 14 '23Sale87.972,000175,94023,948Jul 18 04:16 PM
TEN HOEDT ROBEVP and Pres. Global RegionsJul 10 '23Option Exercise55.325,514305,03447,508Jul 12 03:48 PM
TEN HOEDT ROBEVP and Pres. Global RegionsJul 10 '23Sale86.585,514477,42043,802Jul 12 03:48 PM